Fig. 1: Strategy and prototype of the ATAS.
a The ATAS strategy aims to resolve the obstacles of apheresis in clinical and laboratory practices such as neonatal care, veterinary medicine, and scientific research. b The ATAS strategy uses an acoustofluidic microchip where blood cells, platelets, and plasma are separated in a continuous and stable manner. c Numerical simulation of fluid stabilizing performance. N represents the number of stabilizers. d The acoustofluidic therapeutic apheresis prototype. e Comparison map of the ATAS with other apparatus reported in the literature: (i) ref. 17, (ii) ref. 44, (iii) ref. 45, and (iv) ref. 46. Figure a created with BioRender.com.
